Skip to main content

Table 1 Comparison of Clinical Data

From: Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation

Indexes Normal control group (n = 110) Hepatitis group (n = 127) Cirrhosis group (n = 102) HCC group (n = 143) P
Age (years) 49.4(41.2-60.7) 48.6(37.9-61.2) 51.3(42.2-63.5) 57.8(46.3-67.6) <0.001
Sex (n, %)
 Male 63(57.27) 70(55.12) 59(57.84) 91(63.64) >0.05
 Female 47(42.73) 57(44.88) 43(42.16) 52(36.36)  
ALT (U/L) 19.6(13.2-26.8) 30.2(21.6-50.9) 43.7(30.7-64.2) 70.3(40.1-115.4) <0.001
AST (U/L) 16.3(10.1-23.5) 27.1(19.5-46.3) 40.2(26.0-59.1) 55.1(36.8-90.6) <0.001
GGT (U/L) 17.1(12.5-30.1) 24.4(17.9-31.4) 36.0(27.2-43.5) 98.6(41.2-167.8) <0.001
TBIL (μmol/L) 12.6(9.3-16.7) 18.2(13.0-25.6) 25.3(18.1-33.2) 35.1(20.9-58.3) <0.001
DBIL (μmol/L) 5.1(3.7-7.3) 7.0(5.1-11.2) 10.4(7.2-12.8) 15.7(12.1-27.7) <0.001
ALB (g/L) 43.7(41.2-46.1) 43.3(38.9-45.6) 37.6(33.7-39.6) 32.4(28.7-37.5) <0.001
Plt (109/L) 214.2(180.3-242.7) 196.5(174.2-219.5) 158.3(127.5-177.0) 129.7(93.8-151.6) <0.001
WBC (109/L) 5.7(5.0-6.4) 5.5(4.9-6.2) 4.3(3.1-5.2) 4.1(2.9-5.1) <0.001
RBC (1012/L) 4.8(4.3-5.1) 4.7(4.2-5.2) 3.8(2.9-4.2) 3.2(2.5-3.8) <0.001
Hb (g/L) 145.9(134.8-153.9) 141.7(130.2-150.6) 112.6(96.7-125.1) 90.7(72.7-115.1) <0.001
  1. Abbreviations:ALB albumin, ALT alanine aminotransferase, AST aspartate aminotransferase, DBIL direct bilirubin, GGT gamma-glutamyl transferase, Hb hemoglobin, Plt Platelets, RBC red blood cells, TBIL total direct and indirect bilirubin, WBC white blood cells